Histology and outcomes of newly detected lung lesions in melanoma patients

Annals of Oncology

Volumn 23, Issue 3, 2012, Pages 577-582

  Smyth, E C ^a   Hsu, M ^a   Panageas, K S ^a   Chapman, P B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Lung biopsy; Melanoma; PET; Pulmonary nodules; Smoking

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CANCER; LUNG LESION; LUNG METASTASIS; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DATABASES, FACTUAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84857515816     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr364     Document Type: Article

References (26)

1. Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27(36): 6199-6206.
2. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181: 193-201.
3. Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 2000; 18: 3782-3793.
4. Ollila DW, Hsueh EC, Stern SL, Morton DL. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999; 71: 209-213.
5. Neuman H, Patel A, Hanlon C et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 2007; 14: 2847-2853.
6. Pastorino U, Buyse M, Friedel G et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113: 37-49.
7. Tafra L, Dale PS, Wanek LA et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 1995; 110: 119-129.
8. Petersen RP, Hanish SI, Haney JC et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007; 133: 104-110.
9. Fuster D, Chiang S, Johnson G et al. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 2004; 45: 1323-1327.
10. Dalrymple-Hay MJR, Rome PD, Kennedy C et al. Pulmonary metastatic melanoma-the survival benefit associated with positron emission tomography scanning. Eur J Cardiothorac Surg 2002; 21: 611-615.
11. Strobel K, Dummer R, Husarik DB et al. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology 2007; 244: 566-574.
12. Brady M, Akhurst T, Spanknebel K et al. Utility of preoperative [(18)]F fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Ann Surg Oncol 2006; 13: 525-532.
13. Gulec SA, Faries MB, Lee CC et al. The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making. Clin Nucl Med 2003; 28: 961-965.
14. Ghanem N, Altehoefer C, Högerle S et al. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol 2005; 54: 264-270.
15. Coit DG, Andtbacka R, Bichakjian CK et al. Melanoma. J Natl Compr Canc Netw 2009; 7: 250-275.
16. World Health Organization. Guidelines for Controlling and Monitoring the Tobacco Epidemic. Geneva, Switzerland: WHO 1998.
17. Meyerson SL, Wilson J, Smyth S. Tissue diagnosis of new lung nodules in patients with a known malignancy. Am J Surg 2009; 198: 841-845.
18. Crocetti E, Guzzinati S, Paci E et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries). Melanoma Res 2008; 18: 230-234.
19. Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010; 146: 265-272.
20. Spanogle J, Clarke C, Aroner S, Swetter S. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol 2010; 62: 757-767.
21. Schmid-Wendtner MH, Baumert J, Wendtner CM et al. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001; 145: 981-985.
22. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001; 91: 874-880.
23. Mellemkjær L, Friis S, Olsen JH et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006; 118: 2285-2292.
24. Thellenberg C, Malmer B, Tavelin B, GrÖNberg H. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003; 169: 1345-1348.
25. Xing Y, Bronstein Y, Ross MI et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst 2011; 103: 129-142.
26. Sondak VK, Liu PY, Warneke J et al. Surgical resection for stage IV melanoma: a Southwest Oncology Group trial (S9430). J Clin Oncol (Meeting Abstracts) 2006; 24: (Abstr 8019).